Uterine myoma / fibroid is a benign tumor of the uterine smooth muscle. It forms from the muscle fibers of myometrium, due to the hormonal imbalance. In most cases, uterine myomas are not life threatening but can have a negative impact to the woman’s general health, quality of intimate life and daily routine.
It is the most common gynecological disease of 30-50 year old women. According to statistics, in Europe 40% of women of childbearing age (24 million) have uterine myomas and 25-50% of those women have such symptoms:
- irregular and heavy menstrual period;
- symptoms of anemia (loss of energy, tachycardia, shortness of breath during physical activity, irritability);
- painful and bulging stomach;
- painful sexual intercourse;
- feeling pressure and discomfort in the bladder or stomach;
TREATMENT: The aim of the treatment is to stop or at least reduce menstrual bleeding, shrink or remove the myoma (or myomas) and preserve or bring back fertility.
Methods of treatment:
- total abdominal hysterectomy (TAH), which refers to removal of the entire uterus through the abdominal cavity;
- supracervical abdominal hysterectomy (SAH), which refers to removal of only a part of the uterus (body of uterus), while the cervix is kept intact;
- abdominal myomectomy;
- laparoscopic subtotal hysterectomy, which is the removal of the womb through one of the small surgical incisions on the abdomen with the help of a laparoscope.
- laparoscopic myomectomy;
- laparoscopic uterine artery coagulation;
- hysteroscopic myomectomy (laser, resectoscope);
- uterine artery embolization (UAE);
- focused ultrasound (FUS);
- pharmacological treatment (GnRh-a, SPRM).